Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_assertion type Assertion NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_head.
- NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_assertion description "[Among women with magnesium intake in the lowest 30% (AA: ?0.164 g/d; HA: ?0.185 g/d), 4 SNP signals were strengthened [rs11590362 in claudin 19 (CLDN19), rs823154 in SLC41A1, rs5929706 and rs5930817 in membra; HA: ?0.313 g/d), rs6584273 in CNNM1 (OR: 0.71; FDR-adjusted P = 0.04) and rs1800467 in potassium inwardly rectifying channel, subfamily J, member 11 (KCNJ11) (OR: 2.50; FDR-adjusted P = 0.01) were significantly associated with T2D risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_provenance.
- NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_assertion evidence source_evidence_literature NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_provenance.
- NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_assertion SIO_000772 25733456 NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_provenance.
- NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_assertion wasDerivedFrom befree-2016 NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_provenance.
- NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_assertion wasGeneratedBy ECO_0000203 NP1267651.RAYG7vad1PRUy2Tb8u-BZV9ymIhfG7_ks6PJBWajYF0a0130_provenance.